M 545 (Mirtazapine 45 mg)
Pill imprint M 545 has been identified as Mirtazapine 45 mg.
Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 545
- Strength:
- 45 mg
- Color:
- Beige
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3545
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0088 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about mirtazapine
Consumer resources
- Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
